Uppsala Monitoring Centre

05/02/2026

🤰🏽Pregnant patients are especially vulnerable to due to the potential impact on the patient's health and unborn baby. What should we be aware of to help prevent medication errors during pregnancy?

🔹 Certain medications may cause birth defects or developmental issues
🔹 Physical changes can affect how medications are processed
🔹 Mixing medications with supplements or prenatal vitamins can cause unexpected reactions

Swipe through the images below to learn more👇 and read our interactive Deep Dive for the full story 👉 https://ow.ly/F4q150W5qYF

04/02/2026

From bandages to pacemakers, medical devices play a vital role in modern healthcare and in the daily lives of patients. Monitoring the safety of these devices can be complex, as it must consider not only medical risks, but also technological and engineering risks, such as cybersecurity threats or outdated software.

In this two-part episode, Omar Aimer, President of ISoP Online, breaks down medical device vigilance and shares how global initiatives are working to strengthen safety monitoring standards.

🎧 Listen to for more 👉 https://ow.ly/M36I50Y8JKZ

03/02/2026

💬 Can first-person narratives in online psychedelic forums aid in the detection of emerging safety concerns?

Scientific and therapeutic interest in psychedelics has grown rapidly over the past decade, with widespread recreational use continuing in unregulated settings. Platforms such as Erowid host thousands of user experiences with psychedelics and capture details that formal reporting may miss, such as emotions, settings, and co-substance use.

Ahmed Al-Imam, Manal Mohammed Younus, and Michal Michalak detail how analysis of user narratives could help systems detect risks earlier, support harm-reduction strategies, and guide further research in :

Online psychedelic forums hold untapped safety data. AI analysis of user narratives could help pharmacovigilance systems detect risks missed by traditional reporting.

02/02/2026

Some of the youngest patients are more vulnerable to due to unclear dosing guidelines and a lack of child-specific medications. What should we be aware of to help prevent medication errors in child patients?

🧒🏻 Many medications do not have specific dosing guidelines for children
👧🏼 Medications prescribed for children often require precise calculations based on age, size, and weight
👦🏽 Measuring liquid doses and ensuring children take their full dose make administration errors less likely

Learn more in the images below👇 and read our interactive deep dive for more insights 👉 https://ow.ly/F4q150W5qYF

02/02/2026

📣 Abstract submission is now open for the ISoP Africa Chapter Meeting!

Join ISoP Africa from 19–20 May 2026 in Windhoek, Namibia🇳🇦, as this year's meeting explores opportunities and key challenges for enhancing patient safety in Africa.

Researchers, practitioners, regulators, and pharmacovigilance professionals from across the region are welcome to submit their abstracts for consideration. Topics may include patient-centred PV, digital transformation, PV across the product lifecycle, global and regional partnerships, and much more.

️❗️The deadline to apply is 10 February 2026

Submit your abstract today – more information and instructions available here 👉 https://ow.ly/r4TX50Y7wqH

ISoP Online

30/01/2026

🎥 Malawi has been a member of the World Health Organization (WHO) Programme for International Drug Monitoring (PIDM) since 2016.

Anderson Ndalama from the Pharmacy and Medicines Regulatory Authority shares how the introduction of and has strengthened vaccine safety reporting, improved efficiency and significantly increased the number of AEFI reports submitted.

These tools have also enhanced data sharing between the PMRA and the Expanded Programme on Immunisation (EPI), while fostering stronger collaboration between the EPI and pharmacovigilance teams across health districts.

Watch the film below to hear more of Malawi🇲🇼's Vigiverse journey👇

30/01/2026

We're two Content Specialists to join our Content Management team on a temporary, full-time basis, for a period of one year.

As a Content Specialist, you'll join a team of pharmacists working to ensure drug information is validated and classified in line with the quality standards required for coding in individual case safety reports and clinical trials. The team also contributes to Pharmaceutical Product ID (PhPID) and Global Substance ID (GSID) development in line with the ISO IDMP standards.

Join an organisation with real-world impact. Submit your application by 15 February 2026 👉 https://ow.ly/iBXe50Y5nNl

29/01/2026

How is innovation redefining health systems across borders?

Join UMC's Eva-Lisa Meldau for a panel discussion hosted by the Swedish-Polish Chamber of Commerce to learn more about the forces shaping the next era of life science and healthcare:

📆 Monday, 9 February 2026
🕐 13:00–15:30 CET
📍 Bonnierhuset Konferens, Stockholm 🇸🇪

Register to attend in person 👉 https://ow.ly/E8jb50XXVem

Not in Stockholm? Join the event virtually on LinkedIn 👉 https://ow.ly/C5wW50XXVen

𝘛𝘩𝘪𝘴 𝘦𝘷𝘦𝘯𝘵 𝘪𝘴 𝘱𝘢𝘳𝘵 𝘰𝘧 𝘢 𝘴𝘦𝘮𝘪𝘯𝘢𝘳 𝘧𝘦𝘢𝘵𝘶𝘳𝘪𝘯𝘨 𝘬𝘦𝘺𝘯𝘰𝘵𝘦 𝘱𝘳𝘦𝘴𝘦𝘯𝘵𝘢𝘵𝘪𝘰𝘯𝘴 𝘢𝘯𝘥 𝘤𝘳𝘰𝘴𝘴-𝘴𝘦𝘤𝘵𝘰𝘳 𝘥𝘪𝘴𝘤𝘶𝘴𝘴𝘪𝘰𝘯𝘴 𝘰𝘯 𝘭𝘪𝘧𝘦 𝘴𝘤𝘪𝘦𝘯𝘤𝘦 𝘢𝘯𝘥 𝘩𝘦𝘢𝘭𝘵𝘩𝘤𝘢𝘳𝘦.

27/01/2026

📚 Disproportionality analysis is widely used to detect potential safety signals from adverse drug reaction reports, but inherent biases and data features often cause disproportionality to deviate from causation.

In a recent report, Michele Fusaroli, Joseph Mitchell, Annette Rudolph, Elena Rocca, and Riccardo Fusaroli discuss how the cautious integration of directed acyclic graphs (DAGs) into disproportionality analyses can help synthesize evidence, map biases, and support more qualified causal hypotheses.

at the link below👇

Introduction Disproportionality analysis, finding associations in the co-reporting of drugs and events, is widely used in pharmacovigilance to detect potential safety signals of adverse drug reactions. However, inherent biases and unique data features often cause disproportionality to diverge from c...

26/01/2026

As more young people turn to social media for health advice, introducing regular education on medication safety in schools could help address gaps in and raise public awareness.

Arshia Bhandari and Sangeeta Sharma outline how training programmes, age-appropriate literature, and patient organisations can pave the way for a future where patient safety and health awareness is part of the school curriculum.

Read their article in to find out more👇

As younger generations look to social media for guidance, both medical and otherwise, should health literacy became a part of the school curriculum?

23/01/2026

Underreporting in remains a persistent global challenge.

Historical data suggest that only 2–4% of non-serious and around 10% of serious adverse events are reported each year. With factors such as reporter behaviours and attitudes, limited knowledge, complex procedures, the accessibility of reporting systems, and social and cultural barriers all contributing to its persistence, 𝙝𝙤𝙬 𝙘𝙤𝙪𝙡𝙙 𝙬𝙚 𝙙𝙤 𝙗𝙚𝙩𝙩𝙚𝙧?

In the latest print issue of , we explore how a multi-modal approach is essential to breaking down barriers and addressing the complex web of factors driving underreporting today.

Read more 👉 https://ow.ly/kEv050XSTmK

22/01/2026

𝘋𝘪𝘥 𝘺𝘰𝘶 𝘬𝘯𝘰𝘸? Medication errors aren't limited to just medicines. They can occur in these areas as well:

💉 Vaccines
🩸 Medical devices
💊 Supplements
🩺 Diagnostics

We go beyond medicines in the photos below👇 and into the scope of , those most at risk, and how we can prevent them in our interactive deep dive.

Read for the full picture 👉 https://ow.ly/F4q150W5qYF